New acute onset of ocular myasthenia gravis after COVID-19 vaccine: A case report.

Autor: Chaturvedi HT; Department of Pathology (Branch - Oral Pathology), Care Multispecialty Hospital, Vadodara, Gujarat, India., Patel V; Department of Medicine, SSG Medical College, Vadodara, Gujarat, India., Vasava R; Department of Medicine, Care Multispecialty Hospital, Vadodara, Gujarat, India., Chaturvedi C; Department of Surgery, Care Multispecialty Hospital, Vadodara, Gujarat, India.
Jazyk: angličtina
Zdroj: Journal of family medicine and primary care [J Family Med Prim Care] 2023 Feb; Vol. 12 (2), pp. 394-396. Date of Electronic Publication: 2023 Feb 28.
DOI: 10.4103/jfmpc.jfmpc_1359_22
Abstrakt: Reports have shown the association of coronavirus disease 2019 (COVID-19) with several neuromuscular disorders. Myasthenia gravis (MG) is an autoimmune disease in which antibodies bind to acetyl choline receptors in the postsynaptic membrane at the neuromuscular junction. The characteristic clinical feature of the disease is weakness of the ocular muscle, bulbar muscle, and extremity muscles; when the weakness is limited to the ocular muscle only, the condition is known as ocular myasthenia gravis. Diagnosis is usually confirmed by the acetylcholine receptor antibodies. Symptoms of MG may be aggravated by various types of infections and medications. Here, we are presenting a rare case of a new and acute onset of ocular MG presented after administration of Covishield vaccine.
Competing Interests: There are no conflicts of interest.
(Copyright: © 2023 Journal of Family Medicine and Primary Care.)
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje